Use of covid-19 convalescent plasma to treat covid-19 patients with or without underlying immunodeficiency Post date 7 November 2023 ← Time to treat the climate and nature crisis as one global health emergency → Polycystic ovary syndrome: pathophysiology and therapeutic opportunities